Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.
EMA combines with Cincinnati firm
SYRACUSE – Eric Mower and Associates (EMA) has combined with Cincinnati-based Strata-G Communications, adding 35 people and $35 million in capitalized billings. EMA, based in
New York manufacturing conditions keep rising in January
Business conditions for New York Manufacturers continued to swing upward in January, according to the Federal Reserve Bank of New York’s monthly Empire State Manufacturing
O’Brien & Gere acquires S.C. firm
SYRACUSE – Syracuse-based O’Brien & Gere has acquired the remaining 55 percent ownership of the architecture and engineering firm Lindbergh & Associates of North Charleston,
Founding member leaving Green & Seifter for hospital position
SYRACUSE — Lowell Seifter plans to leave Green & Seifter, Attorneys, PLLC to become general counsel at St. Joseph’s Hospital Health Center. Seifter will surrender
Gallagher Benefit Services wants to expand in Syracuse
SALINA — The head of a national employee-benefits consulting firm’s Syracuse–area office wants to expand the company’s reach in the region over the next several
Syracuse Habitat for Humanity builds up the community
SYRACUSE — Syracuse Habitat for Humanity wrapped up 2011 with a collaboration that offers home ownership to homeless veterans and kicks off the New Year
Malvaso to retire from Toyota Material Handling North America
GREENE — James J. Malvaso, president and CEO of Toyota Material Handling North America (TMHNA), the parent company of The Raymond Corp., will retire effective
Syracuse Orthopedic Specialists moving surgeons to St. Joseph’s Hospital
SYRACUSE — Syracuse Orthopedic Specialists, PC (SOS) plans to increase its presence at St. Joseph’s Hospital Health Center in Syracuse starting next month. Eleven SOS
Q4 consumer confidence falls in Syracuse, rises in Utica and Binghamton
Consumer confidence dropped in Syracuse in the fourth quarter of 2011, diverging from rising confidence levels in most of the state’s other cities — including
Bristol-Myers Squibb to acquire Georgia drug developer
NEW YORK — The biopharmaceutical maker Bristol-Myers Squibb Co. has reached an agreement to acquire clinical-stage biopharmaceutical company Inhibitex, Inc. Bristol-Myers (NYSE: BMY), based in
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.